Avenue Therapeutics Inc (NASDAQ:ATXI)
| 1.05 Delayed Data As of 1:54pm ET |  -0.01 / -0.94%Today’s Change | 0.98 Today|||52-Week Range 16.65 | -9.48% Year-to-Date |
Latest ATXI News | Press Releases
No recent news for Avenue Therapeutics Inc.
Today’s Trading
| Previous close | 1.06 |
| Today’s open | 1.05 |
| Day’s range | 1.04 - 1.05 |
| Volume | 1,104 |
| Average volume (3 months) | 849,862 |
| Market cap | $5.6M |
Data as of 1:54pm ET, 03/21/2023
Growth & Valuation
| Earnings growth (last year) | +29.66% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRVNTrevena Inc | +0.04 | +5.34% |
| SNOASonoma Pharmaceutica... | +0.06 | +5.77% |
| ---- | ||
| NBRVNabriva Therapeutics... | 0.00 | 0.00% |
Data as of 3:55pm ET, 03/21/2023
Financials
| Next reporting date | May 15, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$3.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bay Harbor Islands, Florida |
Forecasts
